0.9% Sodium Chloride Injection
Lack of assurance of sterility: Bags have potential to leak.
Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,681 recalls, newest first.
Lack of assurance of sterility: Bags have potential to leak.
Lack of assurance of sterility: Bags have potential to leak.
Lack of assurance of sterility: Bags have potential to leak.
Presence of foreign substance: glass particles
Presence of Foreign Substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle.
Resuspension problems: Out of specification for appearance and resuspendability.
Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
CGMP Deviations: products may be contaminated with bacteria.
CGMP Deviations: products may be contaminated with bacteria.
CGMP Deviations: products may be contaminated with bacteria.
CGMP Deviations: products may be contaminated with bacteria.
Contraceptive Tablets Out of Sequence.
Labeling: Missing Label
Microbial Contamination of a Non-Sterile Product.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.